相关实验视频

Updated: May 22, 2025

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Published on: March 2, 2020

自然启发的化学诺衍生物可以逆转细菌的耐药性

Qi Wen¹, Yuhang He², Jiaying Chi³

¹Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Rd, Hangzhou, 310058, Zhejiang, China.

European journal of medicinal chemistry

|March 15, 2025

概括

研究人员开发了一种新的基于西普罗素的药物,IPMCL-28b,它模仿了天然的抗微生物. 这种新型抗菌剂有效地对抗多药耐药细菌,并减少耐药性发展,为抗菌素耐药性日益增长的威胁提供了有希望的解决方案.

科学领域:

药用化学医学化学
药理学药理学是指药理学的学科.
微生物学微生物学

背景情况:

抗菌素耐药性 (AMR) 是一个关键的全球健康威胁,需要新的抗菌剂.
广泛使用的抗生素西普洛克萨面临着挑战,原因是细菌耐药性迅速出现.
天然抗微生物 (AMP) 对抗菌素耐药性的敏感性较低,为新药设计提供了灵感.

研究的目的:

设计新型的仿真基因衍生物,模仿宿主防御 (HDPs),以克服抗菌耐药性.
合成和评估这些模仿HDP的化合物对抗多药耐药细菌的疗效和耐药性潜力.

主要方法:

将两性部分纳入西普罗夫洛克萨结构以模仿HDPs.
合成具有特定结构特征的化学化合物IPMCL-28b (刚性链接物,氨基酸,脂性尾巴).
在体外抗菌活性测试,分子动力学模拟,血液溶解试验和体内针对MRSA的疗效研究.

主要成果:

通过破坏细菌细胞膜,IPMCL-28b对抗多药耐药细菌菌株表现出强有力的活性.
分子动力学模拟证实IPMCL-28b与西普洛素相比具有更强的膜破坏性相互作用.
IPMCL-28b 显示出高选择性,低血解,降低了耐药性发展的可能性,并且在体内显著减少了MRSA皮肤细菌负载.

结论:

模仿宿主防御的双胞胎衍生物代表了对抗AMR的有希望的战略.
IPMCL-28b表现出增强的抗微生物活性和降低的耐药性潜力,提供了潜在的治疗选择.
这种方法有可能扭转现有的抗生素耐药性,并缓解未来的耐药性发展.

关键词:

抗微生物耐药性抗微生物耐药性奇米尔基诺隆抗生素奇米尔基诺隆抗生素主体防御的宿主防御.在体内有微生物抗菌活性.膜破坏破坏膜破坏反向耐药性的药物耐药性.

更多相关视频

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Published on: January 1, 2016

相关概念视频

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Antibiotic Selection

Antibiotic Selection

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Genomic DNA in Prokaryotes

Genomic DNA in Prokaryotes

The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...